S&P 500 Industrials Sector SEC Filings — February 02, 2026

03-02-2026

Broadridge Financial Solutions, Inc. filed an 8-K on February 3, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary disclosure for financial results with no specific revenue, earnings, margins, or other quantitative metrics disclosed in the provided filing information. No positive or negative performance indicators, guidance changes, or period-over-period comparisons are mentioned.

03-02-2026

Steele Bancorp Inc filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

03-02-2026

COMMUNITY TRUST BANCORP INC /KY/ filed an 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with AccNo 0000350852-26-000035 and file size 4 MB. No specific financial metrics, transactions, guidance, or operational details are disclosed in the provided filing information. No positive or negative metrics reported.

• ·File size: 4 MB indicates potential substantial exhibits such as presentations or financial tables

03-02-2026

Marathon Petroleum Corp filed a Form 8-K on February 3, 2026 (AccNo: 0001510295-26-000003, size: 745 KB), reporting under Item 2.02 for Results of Operations and Financial Condition, with Item 9.01 for Financial Statements and Exhibits. No revenue, earnings, guidance, balance sheet impacts, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without specific performance details.

• ·AccNo: 0001510295-26-000003

03-02-2026

WM Technology, Inc. filed a multi-item 8-K on February 3, 2026, reporting the termination of a material definitive agreement under Item 1.02 (potentially negative) and departure, election, or appointment of directors or certain officers along with compensatory arrangements under Item 5.02 (mixed implications depending on details). The filing also includes Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative financial impacts, transaction values, or specific details on the events are disclosed.

03-02-2026

M Evo Global Acquisition Corp II filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties, or performance comparisons were disclosed. The filing provides structural updates typical of a SPAC-related merger process but lacks specifics on valuation or strategic rationale.

• ·AccNo: 0001213900-26-010970
• ·File Size: 1 MB
• ·Sector: not specified

03-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are provided in the filing summary. Critical information such as dollar values, percentages, or strategic context is NOT_DISCLOSED.

03-02-2026

THUNDER MOUNTAIN GOLD INC filed an 8-K on 2026-02-03 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, shareholder vote matters or outcomes, fiscal year changes, or contents of exhibits are disclosed. This is a multi-item informational filing with no quantified financial or operational metrics provided.

03-02-2026

Bank of Hawaii Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Filing AccNo: 0000046195-26-000007
• ·Filing size: 324 KB

03-02-2026

Amneal Pharmaceuticals, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item filing indicating a significant corporate transaction, likely involving financing or debt. No specific transaction value, terms, financial metrics, positive or negative impacts, or other quantitative details are disclosed.

• ·Accession Number: 0001628280-26-004738
• ·File Size: 2 MB

03-02-2026

MARZETTI CO filed a Form 8-K on February 3, 2026 (AccNo: 0000057515-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results, but no specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance details are disclosed, rendering the announcement purely structural.

03-02-2026

Voyager Acquisition Corp., a Cayman Islands entity, filed an 8-K on 2026-02-03 (AccNo: 0001829126-26-000900, Size: 749 KB) disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event, with Item 9.01 providing financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing information. Sector is not specified.

03-02-2026

Eaton Corp plc filed a Form 8-K on February 3, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or transaction details were disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative data available.

03-02-2026

Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 03, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). No specific financial metrics, revenue, earnings, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. Additional details on transactions, guidance, or impacts are NOT_DISCLOSED.

03-02-2026

Madison Square Garden Entertainment Corp. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004796), under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided information. No period-over-period comparisons, guidance changes, or balanced positive/negative performance details are available.

03-02-2026

Cipher Mining Inc. filed an 8-K on February 3, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events were disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data available.

03-02-2026

W.W. Grainger, Inc. filed an 8-K on 2026-02-03 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.

03-02-2026

BALL Corp filed an 8-K on 2026-02-03 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are mentioned in the filing details provided. This is a standard earnings-related disclosure with no quantified positive or negative impacts disclosed.

03-02-2026

Liberty Global Ltd. filed an 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure, indicating dissemination of material non-public information, and Item 9.01 Financial Statements and Exhibits, likely attaching related documents. No specific details on the core event, financial metrics, transactions, or performance changes are disclosed in the filing metadata.

03-02-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034474), reporting solely under Item 8.01 Other Events. No core event details, financial metrics, transaction values, period-over-period comparisons, positive or negative changes, or other quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure of a material event not covered by other specific 8-K items.

03-02-2026

GRAPHIC PACKAGING HOLDING CO filed an 8-K on 2026-02-03 reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, positive or negative metrics, or other quantitative financial data are explicitly stated in the provided filing details.

03-02-2026

NextTrip, Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, parties involved, deal terms, or performance impacts are disclosed.

03-02-2026

Prelude Therapeutics Inc filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving a voluntary disclosure of potentially material information via Regulation FD, with exhibits attached. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary.

03-02-2026

Illinois Tool Works Inc filed an 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified performance metrics.

03-02-2026

FS Bancorp, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing likely includes material non-public information via a press release or presentation as an exhibit, but no specific financial metrics, transactions, or performance details are disclosed in the available summary. No positive or negative metrics are mentioned.

03-02-2026

International Endeavors Corp filed an 8-K on February 3, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the attached exhibits are provided. This is a multi-item filing with no quantitative metrics, transactions, or performance data disclosed.

03-02-2026

StoneBridge Acquisition II Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, dates, reasons, financial terms, or quantitative details are mentioned in the filing description. No positive or negative metrics, scheduled events, or merger/acquisition specifics are provided.

03-02-2026

Gladstone Investment Corporation filed an 8-K on February 3, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing summary. No positive or negative financial impacts can be assessed due to lack of quantitative data.

03-02-2026

Northfield Bancorp, Inc. filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance indicators.

03-02-2026

NutriBand Inc. filed a Form 8-K on February 03, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders and Item 9.01: Financial Statements and Exhibits. No specific details on vote matters, outcomes, proposals, or exhibits are disclosed. This appears to be a routine post-shareholder meeting disclosure.

03-02-2026

BayFirst Financial Corp. filed a Form 8-K on 2026-02-03 (AccNo: 0001649739-26-000008, Size: 204 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific financial metrics, transactions, positives, negatives, or flat performance detailed. No quantitative impacts or strategic details are provided in the filing summary.

03-02-2026

03-02-2026

UNITED BANCORP INC /OH/ filed an 8-K on February 03, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This is a standard voluntary disclosure for quarterly or annual results with attached exhibits.

03-02-2026

Enphase Energy, Inc. filed an 8-K on February 3, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing summary. This represents a standard voluntary disclosure of financial results, with no quantitative details available for analysis.

03-02-2026

Transcat Inc filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics.

03-02-2026

InnovAge Holding Corp. filed a Form 8-K on 2026-02-03 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing related to financial results with AccNo 0001834376-26-000012 and size 482 KB. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are explicitly stated.

• ·AccNo: 0001834376-26-000012
• ·Source: us_sec
• ·Sector: not specified

03-02-2026

Applied Energetics, Inc. filed an 8-K on February 3, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 provides for financial statements and exhibits. No quantitative financial details, transaction values, or specific personnel names are disclosed.

03-02-2026

Emerson Electric Co filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. No positive, negative, or flat metrics are available.

03-02-2026

AYTU BIOPHARMA, INC filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data available.

03-02-2026

Dermata Therapeutics, Inc. filed an 8-K on February 3, 2026, reporting changes in its certifying accountant under Item 4.01. The filing also references Item 9.01 for financial statements and exhibits. No specific details on the prior or new accountants, reasons for the change, financial impacts, or other metrics are disclosed.

03-02-2026

Midland States Bancorp, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009720), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or directional impacts are mentioned.

03-02-2026

AMGEN INC filed an 8-K on February 03, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard earnings-related disclosure, but no specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the provided filing summary. No positive or negative performance indicators, period-over-period comparisons, or forward-looking statements were mentioned.

03-02-2026

Bridgeline Digital, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, quantitative impacts, positive developments, or other details were disclosed in the filing summary. This event signals potential removal from a major US exchange.

03-02-2026

Rigel Pharmaceuticals Inc filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or terms were provided. No quantitative financial metrics, performance comparisons, or other numerical data were mentioned.

03-02-2026

Advanced Micro Devices Inc filed an 8-K on February 03, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or forward-looking statements are mentioned.

03-02-2026

Ridgefield Acquisition Corp filed an 8-K on 2026-02-03 disclosing Item 3.03 Material Modifications to Rights of Security Holders, likely related to a merger/acquisition event. Item 9.01 includes Financial Statements and Exhibits. No quantitative details, parties, deal terms, or performance metrics are explicitly stated.

03-02-2026

Mondelez International, Inc. filed an 8-K on February 03, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.

03-02-2026

Sphere Entertainment Co. filed an 8-K on February 3, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

03-02-2026

Bank of Marin Bancorp filed a Form 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, positive or negative changes, or quantitative data are disclosed in the provided filing summary. This is a multi-item informational filing with attached exhibits, likely a press release or presentation, but content details are NOT_DISCLOSED.

03-02-2026

Clorox Co /DE/ filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics in the available filing summary. No positive, negative, or flat performance indicators are detailed.

03-02-2026

ADDENTAX GROUP CORP. filed an 8-K on February 03, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely following a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific voting outcomes, financial metrics, or other details provided in the filing summary.

03-02-2026

8x8 Inc. filed an 8-K on February 3, 2026, disclosing results of operations and financial condition under Item 2.02, along with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

• ·AccNo: 0001023731-26-000006
• ·File size: 8 MB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

03-02-2026

BioNexus Gene Lab Corp filed an 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.

03-02-2026

Ranger Energy Services, Inc. filed a Form 8-K on February 3, 2026, disclosing information under Item 8.01 Other Events. No specific details regarding the nature of the events, financial metrics, transactions, or quantitative data are provided in the filing summary. No positive or negative metrics are mentioned.

03-02-2026

SOLITRON DEVICES INC filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or material impacts are mentioned.

03-02-2026

Artisan Partners Asset Management Inc. filed an 8-K on February 3, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02, with exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information. All quantitative data and named entities remain NOT_DISCLOSED.

03-02-2026

03-02-2026

PHIBRO ANIMAL HEALTH CORP filed an 8-K on February 3, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of the exhibits are disclosed. No financial metrics, transactions, or impacts are mentioned.

03-02-2026

Genworth Financial Inc filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-005054), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional financial data available.

03-02-2026

Prudential Financial Inc filed an 8-K on February 3, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific quantitative metrics, period-over-period comparisons, or guidance details are provided in the filing summary. No positive, negative, or flat performance indicators are explicitly stated.

03-02-2026

Horace Mann Educators Corp /DE/ filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance changes, or period-over-period comparisons are explicitly disclosed in the provided filing information. This appears to be a standard voluntary earnings disclosure with attached exhibits containing detailed metrics.

03-02-2026

Dine Brands Global, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, financial data, or performance comparisons are mentioned.

03-02-2026

SEMrush Holdings, Inc. filed an 8-K on February 3, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, likely following a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific details on vote outcomes, proposals voted on, results, or contents of exhibits are provided. This appears to be a routine post-meeting informational filing with no quantified financial or operational impacts disclosed.

03-02-2026

Dollar General Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual involved, appointment or resignation status, reasons, and any impacts are NOT_DISCLOSED.

03-02-2026

Community West Bancshares filed an 8-K on February 3, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, or events are detailed in the provided filing information. This appears to be a voluntary disclosure with attached exhibits, but content details are not disclosed.

03-02-2026

NOCERA, INC. filed a Form 8-K on 2026-02-03 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. The multi-item filing also reports changes in certifying accountant (Item 4.01), departures or appointments of directors/officers including compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

03-02-2026

TREASURE GLOBAL INC filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01. The filing also reports financial statements and exhibits under Item 9.01. No specific details, financial terms, metrics, or impacts are disclosed.

03-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 3, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction values, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.